ActoBiotics: AG019 (Type 1 Diabetes)
| Source | Web search |
|---|---|
| Organization | Actobio Therapeutics |
| Market status | Under Development |
| Industry | Medical |
| Value chain stage | Finished Product |
| Business models | B2C |
| Product categories | Medical Treatment + Medicine |
| Biotech components | Bacteria |
| Organization type(s) | Private Company |
| Funding types | Private Funding + Shareholder Investment |
| Trading symbol | XON |
| Trading exchange | NASDAQ |
| Notes | Country is Belgium |